Search research articles
Contact Us
Filters
Showing results (21-30 of 64) with videos related to
Page
of 7
Sort By:
Heart Failure Clinics
|
March 28, 2007
Natriuretic peptides in valvular heart diseases
Arti Choure, W H Wilson Tang, Roger M Mills
American Heart Journal
|
December 16, 2014
Estimated prevalence of implanted electrophysiologic devices in patients with heart failure
Roger M Mills, Vivienne Zhu, Robert J Cody, et al.
Clinical Cardiology
|
June 18, 2010
Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction
Domenic Sica, Ron M Oren, Mildred D Gottwald, et al.
The American Journal of Cardiology
|
September 16, 2003
Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation
J Christopher Merritt, Mark Niebauer, Khaldoun Tarakji, et al.
Clinical Cardiology
|
December 17, 2009
Clinical implications of defective B-type natriuretic peptide
Santosh G Menon, Roger M Mills, Ute Schellenberger, et al.
Cardiology
|
September 17, 2003
Does chronic ST segment elevation following Q wave myocardial infarction exclude tissue viability?
Walid Saber, Erna Obenza Nishime, Richard C Brunken, et al.
Cardiology
|
June 3, 2006
Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE
W Frank Peacock, Gregg C Fonarow, Charles L Emerman, et al.
Thrombosis Research
|
August 4, 2012
Initiation of rivaroxaban following low molecular weight heparin for thromboprophylaxis after total joint replacement: the Safe, Simple Transitions (SST) study
Roger M Mills, Richard D Berkowitz, C V Damaraju, et al.
The American Journal of Cardiology
|
April 9, 2008
Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or =55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions
Nancy K Sweitzer, Margarita Lopatin, Clyde W Yancy, et al.
Clinical Cardiology
|
April 9, 2009
Impact of acute serum creatinine elevation in patients treated with nesiritide
Uri Elkayam, Munir Janmohamed, Parta Hatamizadeh, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 64) with videos related to
Sort By:
Page
of 7
Heart Failure Clinics
|
March 28, 2007
Natriuretic peptides in valvular heart diseases
Arti Choure, W H Wilson Tang, Roger M Mills
American Heart Journal
|
December 16, 2014
Estimated prevalence of implanted electrophysiologic devices in patients with heart failure
Roger M Mills, Vivienne Zhu, Robert J Cody, et al.
Clinical Cardiology
|
June 18, 2010
Natriuretic and neurohormonal responses to nesiritide, furosemide, and combined nesiritide and furosemide in patients with stable systolic dysfunction
Domenic Sica, Ron M Oren, Mildred D Gottwald, et al.
The American Journal of Cardiology
|
September 16, 2003
Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation
J Christopher Merritt, Mark Niebauer, Khaldoun Tarakji, et al.
Clinical Cardiology
|
December 17, 2009
Clinical implications of defective B-type natriuretic peptide
Santosh G Menon, Roger M Mills, Ute Schellenberger, et al.
Cardiology
|
September 17, 2003
Does chronic ST segment elevation following Q wave myocardial infarction exclude tissue viability?
Walid Saber, Erna Obenza Nishime, Richard C Brunken, et al.
Cardiology
|
June 3, 2006
Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE
W Frank Peacock, Gregg C Fonarow, Charles L Emerman, et al.
Thrombosis Research
|
August 4, 2012
Initiation of rivaroxaban following low molecular weight heparin for thromboprophylaxis after total joint replacement: the Safe, Simple Transitions (SST) study
Roger M Mills, Richard D Berkowitz, C V Damaraju, et al.
The American Journal of Cardiology
|
April 9, 2008
Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or =55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions
Nancy K Sweitzer, Margarita Lopatin, Clyde W Yancy, et al.
Clinical Cardiology
|
April 9, 2009
Impact of acute serum creatinine elevation in patients treated with nesiritide
Uri Elkayam, Munir Janmohamed, Parta Hatamizadeh, et al.
Page
of 7